Nov 6- Obesity Science & Innovation Europe Post-Event Symposium - Europe/Amsterdam
Nov 6- Obesity Science & Innovation Europe Post-Event Symposium - Europe/Amsterdam
08:00 - 08:3030 mins
Opening Keynote Plenary
Registration
08:30 - 08:4010 mins
Opening Keynote Plenary
Obesity Science & Innovation Europe Welcome
- Kaitlin Dailey - Senior Conference Producer, Obesity Science & Innovation, Informa Connect
08:40 - 08:455 mins
Opening Keynote Plenary
Chair
08:45 - 09:1530 mins
Opening Keynote Plenary
Keynote Presentation: Decoding The Future of Obesity Care: The Signals Worth Paying Attention To
- Ekaterina Grinko - Business Innovation & Partnerships Lead Obesity & GLP-1, Novo Nordisk
09:15 - 10:0550 mins
Opening Keynote Plenary
Keynote Panel: From Lab to Launch - Navigating the European Obesity Therapeutics Landscape
- Annagret Van Der Aaa - CEO, Cantonix Therapeutics
- Ekaterina Grinko - Business Innovation & Partnerships Lead Obesity & GLP-1, Novo Nordisk
- Steffen-Sebastian Bolz - CSO, Aphaia Pharma
- Saleha Patel - Head of Pipeline and Commercialization Strategy, Constructive Bio
10:05 - 10:3530 mins
Opening Keynote Plenary
Morning Break
10:35 - 10:405 mins
Clinical & Translational Updates
Chair
10:40 - 11:0525 mins
Clinical & Translational Updates
Presentation: Exploring A Selective Amylin Receptor Agonist for Metabolic Disease
- Gabe Smolarz - VP Medical Affairs, Zealand Pharma
11:05 - 11:2520 mins
Clinical & Translational Updates
The Obesity Multi-Omic Atlas: Driving Target Discovery
- Jeremie Boucher - SVP, Head of Metabolic Disease, Evotec
11:25 - 11:5025 mins
Clinical & Translational Updates
Presentation: Genetically-Validated INHBE Silencing with SLN098 siRNA for Enhanced Fat Loss and Lean Mass Preservation
- Lucas Bethge, Ph.D. - VP, Group Leader Chemistry, Silence Therapeutics
11:50 - 12:1525 mins
Clinical & Translational Updates
Presentation: Energy Expenditure Modulation as an Emerging Therapeutic Strategy for Obesity
- Martin Hey-Mogensen - Scientific Director, Emerging Obesity Mechanism, The Energy Expenditure Group, Novo Nordisk
12:15 - 13:2570 mins
Clinical & Translational Updates
Lunch Break
13:25 - 13:305 mins
Technology and Process Innovation Spotlight
Chair
13:30 - 13:5020 mins
Technology and Process Innovation Spotlight
Presentation: Engineering Advanced GLP-1 Peptides Through Targeted Site-Specific Modifications
- Robert Salmon - Head of Bioprocess, Constructive Bio
13:50 - 14:1020 mins
Technology and Process Innovation Spotlight
Presentation: Investigating FKBPL as an Emerging Metabolic Target in Obesity
- Stephanie Annett - Senior Lecturer, RCSI
14:10 - 14:3020 mins
Technology and Process Innovation Spotlight
Presentation: Enteroendocrine Cell Activation via Beaded Oral Glucose: A Multi-Hormonal Approach to Metabolic Regulation
- Steffen-Sebastian Bolz - CSO, Aphaia Pharma
14:30 - 14:5020 mins
Technology and Process Innovation Spotlight
Presentation: Translational Medicine at the Crossroads of Obesity and Type 2 Diabetes: From Disease Mechanisms to Precision Therapeutics
- Farhad Rezaee - Principle Investigator/ Project Leader, Erasmus Medical Center Rotterdam
14:50 - 15:1020 mins
Technology and Process Innovation Spotlight
Presentation: First-in-Class Small Molecule Targeting Adipocyte Futile Cycling for Weight Loss
- Joanne Hsieh, PhD - Head of Metabolism, Gordian Biotechnology
15:10 - 15:4030 mins
Technology and Process Innovation Spotlight
Afternoon Break
15:40 - 16:0525 mins
Afternoon Keynote Plenary
Keynote Presentation: The Missing Signal in Obesity Care: Turning Everyday Patient Data into Better Clinical Conversations
- Marcello Duhalde - CGO, Smart Patient
16:05 - 16:3025 mins
Afternoon Keynote Plenary
Keynote Presentation: Weight A Minute: The Patient Perspective
- Natasja Wijling - Board Member & Patient Advocate, Dutch Association for Overweight & Obesity (NVOO)
* 주최측 사정에 따라 사전 예고없이 프로그램이 변경될 수 있습니다.